DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Bisphosphonate
Bisphosphonate
1.1. Bisphosphonates and Depressive Reactions
Association Between Oral Anticoagulants and Osteoporosis
Proton Pump Inhibitors and Fracture Risk: a Review of Current Evidence and Mechanisms Involved
Prevention of Glucocorticoid-Induced Osteoporosis
Bisphosphonates: Mechanisms of Action
Conjugated Bisphosphonate with High Affinity for Bone As a Bone
Legacy Drug-Prescribing Patterns in Primary Care
Denosumab: a New Therapy for Osteoporosis Editor by Candice Gehret, Pharm.D
Osteoporosis in Depression: Which Patients Are at Risk?
Dr Alex Comninos
Guidelines for Bisphosphonate-Associated Osteonecrosis of the Jaw
Risks of Bisphosphonate
(Alendronate) Initiation After Surgery for Fragility Fracture: a Population-Based Cohort Study
Bisphosphonates and Glucocorticoid-Induced
Synergistic Autophagy Effect of Mir-212-3P in Zoledronic Acid
Case Study of Hydrometra and Uterine Adenocarcinoma in a Pet Rabbit
Osteonecrosis of the Jaw Related to Everolimus and Bisphosphonate: a Unique Case Report?
Combined Therapy with a New Bisphosphonate, Minodronate
Top View
Update in Geriatrics
Summary of Product Characteristics
FOSAMAX PLUS D Safely and Effectively
PBC Primary Biliary Cholangitis Treatment and Management
Bisphosphonate Therapy
Primary Biliary Cirrhosis View Online At
The Change of Bone Mineral Density by Bisphosphonates Therapy with Calcium-Antagonists in Osteoporosis
Bisphosphonate Treatment: an Orthodontic Concern Calling for a Proactive Approach
1 American Association of Oral and Maxillofacial Surgeons Position
Use of Anti-Osteoporosis Medication Dispensing by Patients with Hip Fracture: Could We Do Better?
Zoledronic Acid Potentiates Mtor Inhibition and Abolishes the Resistance of Osteosarcoma Cells to RAD001 (Everolimus): Pivotal Role of the Prenylation Process
Adjuvant Bisphosphonate
Bisphosphonate Safety
Perio Reports Vol. 22 No. 9 Perio Reports Provides Easy-To-Read Research Summaries on Topics of Specific Interest to Clinicians
(70 Mg/70 Mcg Tablet) FOSAMAX PLUS™ 70/140
Primary Sjogren Syndrome Increases the Risk of Bisphosphonate-Related
BMD at Bisphosphonate's End Predicts Fractures
Bisphosphonate-Associated Osteonecrosis